Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Co Q10 10mg capsules
091102000BBAPBB
|
Proprietary compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | No data available |
|
Co-amilofruse 1.25mg/10mg/5ml oral liquid
0202040B0AAAMAM
|
Co-amilofruse | Co-amilofruse (Amiloride hydrochloride/frusemide) | Cardiovascular System | No data available |
|
Co-amilofruse 10mg/80mg/5ml oral liquid
0202040B0AAAIAI
|
Co-amilofruse | Co-amilofruse (Amiloride hydrochloride/frusemide) | Cardiovascular System | No data available |
|
Co-amilofruse 2.5mg/20mg/5ml oral liquid
0202040B0AAAJAJ
|
Co-amilofruse | Co-amilofruse (Amiloride hydrochloride/frusemide) | Cardiovascular System | No data available |
|
Co-amilozide 5mg/50mg/5ml oral solution
0202040C0AAACAC
|
Co-amilozide | Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | Cardiovascular System | No data available |
|
Co-amoxiclav 250mg/125mg dispersible tablets sugar free
0501013K0AAABAB
|
Co-amoxiclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | No data available |
|
Co-beneldopa 12.5mg/50mg/5ml oral suspension
0409010K0AAANAN
|
Co-beneldopa | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | No data available |
|
Co-beneldopa 25mg/100mg/5ml oral liquid
0409010K0AAAHAH
|
Co-beneldopa | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | No data available |
|
Co-beneldopa 25mg/6.25mg/5ml oral suspension
0409010K0AAAPAP
|
Co-beneldopa | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | No data available |
|
Co-Betaloc SA tablets
0204000W0BBABAB
|
Co-Betaloc | Metoprolol tartrate with diuretic | Cardiovascular System | No data available |
|
Co-Betaloc tablets
0204000W0BBAAAA
|
Co-Betaloc | Metoprolol tartrate with diuretic | Cardiovascular System | No data available |
|
Co-careldopa 10mg/100mg/5ml oral suspension
0409010N0AAAJAJ
|
Co-careldopa | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | No data available |
|
Co-careldopa 10mg/40mg/5ml oral suspension
0409010N0AAAYAY
|
Co-careldopa | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | No data available |
|
Co-careldopa 2.5mg/10mg/5ml oral suspension
0409010N0AAAQAQ
|
Co-careldopa | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | No data available |
|
Co-careldopa 25mg/250mg/5ml oral suspension
0409010N0AAAIAI
|
Co-careldopa | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | No data available |
|
Co-careldopa 5mg/50mg/5ml oral suspension
0409010N0AAAXAX
|
Co-careldopa | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | No data available |
|
Co-careldopa 625microgram/2.5mg/5ml oral suspension
0409010N0AAATAT
|
Co-careldopa | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | No data available |
|
Co-codamol 30mg/500mg effervescent powder sachets sugar free
0407010F0AAAQAQ
|
Co-codamol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | No data available |
|
Co-codamol 60mg/1000mg effervescent pdr sachets sugar free
0407010F0AAARAR
|
Co-codamol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | No data available |
|
Co-codamol 60mg/1000mg tablets
0407010F0AAAYAY
|
Co-codamol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | No data available |
|
Co-codamol 8mg/500mg/5ml oral liquid
0407010F0AAASAS
|
Co-codamol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | No data available |
|
Co-codaprin 8mg/400mg dispersible tablets
0407010M0AAABAB
|
Co-codaprin | Co-codaprin (Codeine phosphate/aspirin) | Central Nervous System | No data available |
|
Co-codaprin 8mg/400mg tablets
0407010M0AAAAAA
|
Co-codaprin | Co-codaprin (Codeine phosphate/aspirin) | Central Nervous System | No data available |
|
Co-danthramer 25mg/200mg capsules
0106020B0AAACAC
|
Co-danthramer | Co-danthramer (Dantron/poloxamer 188) | Gastro-Intestinal System | No data available |
|
Co-danthramer 25mg/200mg/5ml oral suspension
0106020B0AAAHAH
|
Co-danthramer | Co-danthramer (Dantron/poloxamer 188) | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.